1,398 Shares in Axon Enterprise, Inc $AXON Bought by Cyndeo Wealth Partners LLC

Cyndeo Wealth Partners LLC acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 1,398 shares of the biotechnology company’s stock, valued at approximately $1,157,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AXON. Brighton Jones LLC acquired a new position in Axon Enterprise during the fourth quarter worth $480,000. Harbor Capital Advisors Inc. acquired a new position in Axon Enterprise during the first quarter worth $587,000. GAMMA Investing LLC grew its holdings in Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after acquiring an additional 154 shares during the period. Integrated Advisors Network LLC acquired a new position in Axon Enterprise during the first quarter worth $656,000. Finally, CX Institutional acquired a new position in Axon Enterprise during the first quarter worth $115,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of the stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares in the company, valued at $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 59,932 shares of company stock valued at $45,115,616. Insiders own 4.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on AXON. Northland Securities set a $800.00 price objective on Axon Enterprise in a report on Tuesday, August 5th. JMP Securities reiterated a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Morgan Stanley set a $885.00 target price on Axon Enterprise and gave the stock an “overweight” rating in a research report on Friday, July 11th. Bank of America boosted their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Stock Down 4.2%

Shares of NASDAQ:AXON opened at $703.03 on Friday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91. The stock’s fifty day simple moving average is $755.57 and its 200-day simple moving average is $712.63. The company has a market capitalization of $55.19 billion, a P/E ratio of 173.59, a P/E/G ratio of 28.50 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same period in the prior year, the business earned $1.20 earnings per share. The business’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.